We protect your health through science

Investigación

Malaria and Emerging Parasitosis

Líneas de investigación

Content with Investigacion Neumococos .

Neumococos

Vigilancia epidemiológica de los serotipos y genotipos que causan enfermedad neumocócica invasiva (ENI) en España. Caracterización molecular de factores de virulencia de neumococo. Identificación y caracterización de proteínas de neumococo candidatas a vacuna. Evaluación de mecanismos de evasión de la respuesta inmune en Streptococcus pneumoniae. Impacto de los biofilms bacterianos en la persistencia del tracto respiratorio. Mecanismos de cronicidad de aislados clínicos de neumococo en pacientes con enfermedad pulmonar obstructiva crónica.

Custom

Publicaciones destacadas

Category
Sort

Accuracy of molecular drug susceptibility testing amongst tuberculosis patients in Karakalpakstan, Uzbekistan.

Gil H, Margaryan H, Azamat I, Ziba B, Bayram H, Nazirov P, Gomez D, Singh J, Zayniddin S, Parpieva N and Achar J. Trop. Med. Int. Health. 2021. 26:421-427.

PUBMED DOI

High-Resolution Melting Assay to Detect the Mutations That Cause the Y132F and G458S Substitutions at the ERG11 Gene Involved in Azole Resistance in Candida parapsilosis

Nuria Trevijano-Contador, Elena López-Peralta, Jorge López-López, Alejandra Roldán, Cristina de Armentia, Óscar Zaragoza. Mycoses 2024 Nov;67(11):e13811

PUBMED DOI

Broad Protection against Invasive Fungal Disease from a Nanobody Targeting the Active Site of Fungal β-1,3-Glucanosyltransferases

Redrado-Hernández S, Macías-León J, Castro-López J, Belén Sanz A, Dolader E, Arias M, González-Ramírez AM, Sánchez-Navarro D, Petryk Y, Farkaš V, Vincke C, Muyldermans S, García-Barbazán I, Del Agua C, Zaragoza O, Arroyo J, Pardo J, Gálvez EM, Hurtado-Guerrero R. Angew Chem Int Ed Engl. 2024 Aug 19;63(34):e202405823.

PUBMED DOI

Diagnósitico microbiológico y control de la legionelosis

Pelaz Antolín, C., et al., En Procedimientos en Microbiología Clínica, E.C.y.R. Cantón, Editor. 2005, SEIMC. p. 1-72.

PUBMED

Content with Investigacion Neumococos .

List of staff

Información adicional

Despite progress, parasitic diseases remain a major challenge for humans. Its rapid and accurate detection, as well as the identification of specific genes related to virulence and/or resistance to treatments, is a necessity for management and planning control strategies. 

The main objective of the group is to carry out quality, competitive and innovative research, to acquire, disseminate and apply in clinical parasitology with the ultimate goal of improving and innovating in the diagnoses, therapies and control of parasitic diseases. This general objective is implemented through external projects and collaborations with different funding sources:

- Characterization of submicroscopic malaria. National Hospital Network. (FIS-ISCIII).
- Design, optimization and validation of advanced diagnostic methods for the detection of blood parasites (Retos-MICINN).
- Control of onchocerciasis in Equatorial Guinea. CNMTrop-ISCIII (Task Force, USA).
- Characterization and control of Mansonellosis and Onchocerciasis in the Amazon region in Brazil. FIOCRUZ from Amazonas, Brazil. (Cpnqt-Brazil).
- Plasmodium knowlesi and its implication as the fifth species of human malaria. MRC, Malaysia.
- Intestinal parasitosis in Egypt from Cryptosporidium (protozoan) to Capillaria (Nematode). Cairo University and Al-Azhar University, Egypt. (MHESR, AECID).

Content with Investigacion Neumococos .